中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2009年
3期
1-2
,共2页
陈幼明%张广铮%林潮双%朱建芸
陳幼明%張廣錚%林潮雙%硃建蕓
진유명%장엄쟁%림조쌍%주건예
血浆置换%持续性血液透析滤过%重型肝炎%预后
血漿置換%持續性血液透析濾過%重型肝炎%預後
혈장치환%지속성혈액투석려과%중형간염%예후
Plasma exchange%Continuous hemodiafiltration%Severe hepatitis%Prognosis
目的探讨血浆置换(plasma exchange,PE)联合持续性血液透析滤过(continuous hemodi-afihration,CHDF)治疗重型肝炎的近期疗效.方法 2002年1月至2006年12月期间在我科住院的慢性乙型重型肝炎患者181例随机分2组,A组87例内科综合治疗+PE+CHDF,B组94例内科综合治疗+PE,比较两组治疗后近期疗效及生存率,并观察两组治疗前后临床症状及实验室结果的改变.结果两组治疗后在近期有效率、意识转清率、改善电解质等方面有差异(P<0.01),A组优于B组,在降低胆红素(TBIL)、改善凝血酶原活动度(PTA)及白蛋白(ALB)方面无差异(P>0.05).结论内科综合治疗+PE+CHDF能提高慢性乙型重型肝炎患者近期生存率和意识转清率,可有效纠正电解质紊乱,保持内环境平衡.
目的探討血漿置換(plasma exchange,PE)聯閤持續性血液透析濾過(continuous hemodi-afihration,CHDF)治療重型肝炎的近期療效.方法 2002年1月至2006年12月期間在我科住院的慢性乙型重型肝炎患者181例隨機分2組,A組87例內科綜閤治療+PE+CHDF,B組94例內科綜閤治療+PE,比較兩組治療後近期療效及生存率,併觀察兩組治療前後臨床癥狀及實驗室結果的改變.結果兩組治療後在近期有效率、意識轉清率、改善電解質等方麵有差異(P<0.01),A組優于B組,在降低膽紅素(TBIL)、改善凝血酶原活動度(PTA)及白蛋白(ALB)方麵無差異(P>0.05).結論內科綜閤治療+PE+CHDF能提高慢性乙型重型肝炎患者近期生存率和意識轉清率,可有效糾正電解質紊亂,保持內環境平衡.
목적탐토혈장치환(plasma exchange,PE)연합지속성혈액투석려과(continuous hemodi-afihration,CHDF)치료중형간염적근기료효.방법 2002년1월지2006년12월기간재아과주원적만성을형중형간염환자181례수궤분2조,A조87례내과종합치료+PE+CHDF,B조94례내과종합치료+PE,비교량조치료후근기료효급생존솔,병관찰량조치료전후림상증상급실험실결과적개변.결과량조치료후재근기유효솔、의식전청솔、개선전해질등방면유차이(P<0.01),A조우우B조,재강저담홍소(TBIL)、개선응혈매원활동도(PTA)급백단백(ALB)방면무차이(P>0.05).결론내과종합치료+PE+CHDF능제고만성을형중형간염환자근기생존솔화의식전청솔,가유효규정전해질문란,보지내배경평형.
Objective To explore the short-term therapeutic effect of plasma exchange combined with continuous hemodiafiltration on patients with severe hepatitis. Methods 181 in patients in our department dur-ing Jan. 2002 to Dec. 2006 with chronic severe hepatitis caused by hepatitis B were randomly divided into two groups: Patients of group A (n=87) were treated with internal medicine supporting treatment combined with PE and CHDF,while patients of group B(n=94) were treated with internal medicine supporting treatment com-bined with PE. The short-term therapeutic effect and survival rate were compare and the clinical symptoms and the laboratory examination were determined before and after the treatment. Results There were significant difference between the two groups in short-term efficacy rate,improvement rate of consciousness and serum elee-trolure(P<0.01). There was no significant difference between the two groups in the total bilirubin decreasing,PTA improving and the albumin changing (P>0.05). Conclusion Internal medicine supporting treatment combined with PE and. CHDF can increase the recent survival rate and improve the consciousness of hepatic en-eephalopathy, and it also effectively redress electrolyte disturbance in serum and keep homeostatic equilibrium of patients; furthermore,this treatment is also convenience and safe, so it can be taken as the major method in treatment of severe hepatitis.